European Society of Cardiology
 
  Login  Home About Us Contact Us Site Map
 Home > Knowledge Centre > Online Learning & Teaching > ESC Slide Resource > ESC Congress 2004 Munich
Online Learning & Teaching
Webcasts
ESC Slide Resource
World Congress of Cardiology - ESC Congress 2006
ESC Congress 2005 Stockholm
ESC Congress 2004 Munich
ESC Congress 2003 Vienna
Management of CVD Risk in the Perimenopausal Woman 2006
EACPR Leuven Spring Meeting 2005
Heart Failure 2005
ESC Policy Conference on CVD in Women
Education in Heart
Educational Programme Resources
 
Scientific and Knowledge Search
Clinical Case Portal
Echocardiography
Heart Failure Scientific Reports
CME Calendar

How many pills do patients with heart failure actually take?

Print version


Presentation title: How many pills do patients with heart failure actually take?
Author(s): Erdmann E. (Cologne, DE)
Date: 31 August 2004
[Download complete file]
 
Click a thumbnail below to view an individual slide:

How many pills do patients with CHF actually take?

Polypharmacy in the General Population (self reporting in interviews)


Polypharmacy in CHF in Switzerland 1999 (n = 474, outpatients, 75 + 12 years, Improvement of HF)

The Mahler Study (1410 CHF-Patients in France, Germany, Italy, Spain, UK, NL)

The MAHLER-Study

The Mahler Study (n=1410 CHF-Patients) (France, Germany, Italy, Spain, UK, NL)

The Mahler Study (n=1410 CHF-Patients) (France, Germany, Italy, Spain, UK, NL)


Basic demographic and clinical characteristics in the CARE-HF study

Comparison of Prescribing Habits in Controlled Studies versus Ambulatory Care in Patients with Coronary Heart Disease

Age Dependent CHF – Therapy in Switzerland 1999


Lesson from the IMPACT-HF Trial (Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure) (prospective, randomized open label, > 30-60 days after discharge, n = 363) (EF < 40 %, mean 25 %, hospitalised because of heart failure)



Drugs stored at home by elderly patients (n = 195, > 75 years, 6 months after hospitalisation, visited by research nurse)

Non-Compliance in Germany

Compliance in Polypharmacotherapy (Cardiovascular therapy)

Polypharmacy a Problem of Evidence Based Medicine?

More Potential Drug Interactions Because of Evidence Based Medicine?

Problems of Polypharmacy in CHF

Polypharmacy – which drugs are involved? (n = 466.567 inhabitants of Funen/DK, 5443 users of 5 or more drugs)

Polypharmacy in Cardiovascular Disease



Herbal supplements may have yet unknown interactions:

To Take or not to Take the Drug ?

Solutions ???
 
Sign up here to receive the My ESC News or ESC Newsletter
Visit the beta version of the new ESC Web Site


There are no polls available right now.
Site Map | Contact Us | Terms & Conditions Privacy
 
Copyright © European Society of Cardiology 1997 - 2005 - All rights reserved